Sonoma pharmaceuticals reports qtrly loss per share of $0.77

Sonoma pharmaceuticals reports fiscal year and fourth quarter 2020 financial results.q4 revenue rose 5 percent to $4.6 million.qtrly loss per share $0.77.as of march 31, 2020, sonoma had cash and cash equivalents of $3.7 million.

SNOA Ratings Summary

SNOA Quant Ranking